Annual CFI
$15.00 M
+$68.86 M+127.84%
December 31, 2023
Summary
- As of February 8, 2025, VIRX annual cash flow from investing activities is $15.00 million, with the most recent change of +$68.86 million (+127.84%) on December 31, 2023.
- During the last 3 years, VIRX annual CFI has risen by +$15.05 million (+27369.09%).
- VIRX annual CFI is now at all-time high.
Performance
VIRX Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
$8.16 M
-$3.54 M-30.27%
September 30, 2024
Summary
- As of February 8, 2025, VIRX quarterly cash flow from investing activities is $8.16 million, with the most recent change of -$3.54 million (-30.27%) on September 30, 2024.
- Over the past year, VIRX quarterly CFI has dropped by -$1.11 million (-11.97%).
- VIRX quarterly CFI is now -52.40% below its all-time high of $17.14 million, reached on March 31, 2021.
Performance
VIRX Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
$43.33 M
-$938.00 K-2.12%
September 30, 2024
Summary
- As of February 8, 2025, VIRX TTM cash flow from investing activities is $43.33 million, with the most recent change of -$938.00 thousand (-2.12%) on September 30, 2024.
- Over the past year, VIRX TTM CFI has increased by +$28.33 million (+188.87%).
- VIRX TTM CFI is now -2.12% below its all-time high of $44.26 million, reached on June 30, 2024.
Performance
VIRX TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
VIRX Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +127.8% | -12.0% | +188.9% |
| 3 y3 years | +10000.0% | -12.0% | +188.9% |
| 5 y5 years | +10000.0% | -12.0% | +188.9% |
VIRX Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +127.8% | -42.5% | +115.7% | -2.1% | +170.8% |
| 5 y | 5-year | at high | +127.8% | -52.4% | +115.7% | -2.1% | +170.8% |
| alltime | all time | at high | +127.8% | -52.4% | +115.7% | -2.1% | +170.8% |
Viracta Therapeutics Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $8.16 M(-30.3%) | $43.33 M(-2.1%) |
| Jun 2024 | - | $11.70 M(-17.5%) | $44.26 M(+21.1%) |
| Mar 2024 | - | $14.19 M(+53.1%) | $36.54 M(+143.6%) |
| Dec 2023 | $15.00 M(-127.8%) | $9.27 M(+1.9%) | $15.00 M(+171.5%) |
| Sep 2023 | - | $9.10 M(+128.6%) | $5.53 M(-109.9%) |
| Jun 2023 | - | $3.98 M(-154.1%) | -$55.63 M(-9.1%) |
| Mar 2023 | - | -$7.35 M(+3520.7%) | -$61.22 M(+13.6%) |
| Dec 2022 | -$53.87 M | -$203.00 K(-99.6%) | -$53.87 M(+0.3%) |
| Sep 2022 | - | -$52.06 M(+3141.4%) | -$53.68 M(+817.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | -$1.61 M(<-9900.0%) | -$5.85 M(+37.7%) |
| Mar 2022 | - | $0.00(-100.0%) | -$4.25 M(-133.0%) |
| Dec 2021 | $12.89 M(<-9900.0%) | -$19.00 K(-99.6%) | $12.89 M(-0.1%) |
| Sep 2021 | - | -$4.23 M(>+9900.0%) | $12.91 M(-24.6%) |
| Jun 2021 | - | -$5000.00(-100.0%) | $17.13 M(+0.3%) |
| Mar 2021 | - | $17.14 M(>+9900.0%) | $17.09 M(<-9900.0%) |
| Dec 2020 | -$55.00 K | $0.00(-100.0%) | -$55.00 K(0.0%) |
| Sep 2020 | - | -$5000.00(-90.0%) | -$55.00 K(+10.0%) |
| Jun 2020 | - | -$50.00 K(<-9900.0%) | -$50.00 K(<-9900.0%) |
| Mar 2020 | - | $0.00 | $0.00 |
FAQ
- What is Viracta Therapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for Viracta Therapeutics?
- What is Viracta Therapeutics annual CFI year-on-year change?
- What is Viracta Therapeutics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Viracta Therapeutics?
- What is Viracta Therapeutics quarterly CFI year-on-year change?
- What is Viracta Therapeutics TTM cash flow from investing activities?
- What is the all time high TTM CFI for Viracta Therapeutics?
- What is Viracta Therapeutics TTM CFI year-on-year change?
What is Viracta Therapeutics annual cash flow from investing activities?
The current annual CFI of VIRX is $15.00 M
What is the all time high annual CFI for Viracta Therapeutics?
Viracta Therapeutics all-time high annual cash flow from investing activities is $15.00 M
What is Viracta Therapeutics annual CFI year-on-year change?
Over the past year, VIRX annual cash flow from investing activities has changed by +$68.86 M (+127.84%)
What is Viracta Therapeutics quarterly cash flow from investing activities?
The current quarterly CFI of VIRX is $8.16 M
What is the all time high quarterly CFI for Viracta Therapeutics?
Viracta Therapeutics all-time high quarterly cash flow from investing activities is $17.14 M
What is Viracta Therapeutics quarterly CFI year-on-year change?
Over the past year, VIRX quarterly cash flow from investing activities has changed by -$1.11 M (-11.97%)
What is Viracta Therapeutics TTM cash flow from investing activities?
The current TTM CFI of VIRX is $43.33 M
What is the all time high TTM CFI for Viracta Therapeutics?
Viracta Therapeutics all-time high TTM cash flow from investing activities is $44.26 M
What is Viracta Therapeutics TTM CFI year-on-year change?
Over the past year, VIRX TTM cash flow from investing activities has changed by +$28.33 M (+188.87%)